Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study information regarding the safety and efficacy of MRTX849 in combination with TNO155 for treating advanced solid tumors with a KRAS G12C mutation, while also updating the revision number.SummaryDifference15%
- Check29 days agoChange DetectedThe page has been updated to reflect the completion status and the latest revision version, moving from v2.14.3 to v2.14.4, while also changing the date references to more current ones.SummaryDifference1%
- Check73 days agoChange DetectedThe page has added several new local institutions while removing multiple prominent cancer centers and specific dates, indicating a shift in focus towards local resources.SummaryDifference10%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.